Active cancer therapy combined with TCM probably leads to lower adverse events ‐ arrest of bone marrow compared with active cancer therapy (moderate certainty).
Active cancer therapy combined with TCM may leads to lower adverse events ‐ radiation oesophagitis compared with active cancer therapy (low certainty).
Active cancer therapy combined with TCM showed no clear difference in adverse events ‐ mucositis Diagnosed by clinicians compared with active cancer therapy (low certainty).
Active cancer therapy combined with TCM showed no clear difference in adverse events ‐ neurotoxicity Diagnosed by clinicians compared with active cancer therapy (low certainty).
Active cancer therapy combined with TCM showed no clear difference in adverse events ‐ cardiac toxicity Diagnosed by clinicians compared with active cancer therapy (low certainty).
It is very uncertain whether active cancer therapy combined with TCM changes adverse events ‐ white blood cell descent Diagnosed by clinicians compared with active cancer therapy (very low certainty).
It is very uncertain whether active cancer therapy combined with TCM changes adverse events ‐ gastrointestinal reactions Diagnosed by clinicians compared with active cancer therapy (very low certainty).
Active cancer therapy combined with TCM may leads to lower adverse events ‐ renal and hepatic impairment ‐ Fuzheng Guben granules compared with active cancer therapy (low certainty).
Active cancer therapy combined with TCM showed no clear difference in adverse events ‐ renal and hepatic impairment‐ Xiaoaiping Diagnosed… compared with active cancer therapy (low certainty).
It is very uncertain whether oral iron sulphate changes serious adverse events ‐ active or inactive disease (14 days) compared with oral iron hydroxide polymaltose complex (very low certainty).
Oral 5‐ASA probably leads to lower adverse events compared with SASP (moderate certainty).
Once daily dosing showed no clear difference in adverse events compared with conventional dosing (moderate certainty).
Oral 5‐ASA showed no clear difference in adverse events compared with comparator 5‐ASA (moderate certainty).
Oral 5‐ASA showed no clear difference in adverse events compared with placebo (high certainty).
The review found no eligible studies for this question.
Antibiotic with anti‐TNF showed no clear difference in adverse events compared with placebo with anti‐TNF (moderate certainty).
Antibiotic showed no clear difference in adverse events compared with placebo (high certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.